JelloX Biotech Achieves A Major Milestone in Regulatory Approval

The 1st Digital Pathology Software as Medical Device is Approved by TFDA

Today JelloX “MetaLite DX Digital Pathology Software” just received TFDA approval. It is the first digital pathology product that can be used offline in Taiwan.

CEO Yen-Yin Lin shares unique features of this product- a stand-alone design that can be easily installed on edge computing devices and used independently on PC or laptop, opening a new era of personal intelligent pathology in support of precision diagnosis.

JelloX Biotech Inc. has built up an “advanced pathology knowledge management” ecosystem including flexible modules supporting smart pathology management, edge digital pathology analysis, and digital pathology verification platform. We expect more successful installation of JelloX solution in domestic medical centers and international sites, creating wide open business opportunity in next generation pathology.